Rivey, Michael P.

English

University of Montana

University of Montana ScholarWorks at University of Montana Syllabi Course Syllabi Fall 9-1-2001 PHAR 571.01: Integrated Studies IV Michael P. Rivey University of Montana, Missoula Follow this and additional works at: https://scholarworks.umt.edu/syllabi Let us know how access to this document benefits you. Recommended Citation Rivey, Michael P., "PHAR 571.01: Integrated Studies IV" (2001). Syllabi. 6205. https://scholarworks.umt.edu/syllabi/6205 This Syllabus is brought to you for free and open access by the Course Syllabi at ScholarWorks at University of Montana. It has been accepted for inclusion in Syllabi by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact scholarworks@mso.umt.edu.  Pharmacy 553 Pharm.D.:  Therapeutics III Fall 2001  Lectures:   M-W-F 1110-1200 Skaggs Bldg Rm 117   F only  1010-1100      “           Rm 114  Course Coordinator: Michael Rivey  ====>  M. Rivey Instructors:   Douglas Allington         Office:  243-6796     Rose Macklin      Community Hosp: 327-4299     Cathy Bartels                 ext. 7605     Sarah Miller               Pager: 329-6122     Gayle Cochran   Home: 251-3369     Donna Beall     Lee Ann Bradley      Material and Resources  Required Texts: DiPiro Pharmacotherapy, 4th edition APhA:  Handbook of Nonprescription Drugs     Medical Letter on Drugs & Therapeutics     Goodman & Gilman's Pharmacological Basis of Therapeutics     Boh Pharmacy Practice Manual     A medical dictionary   Optional Texts: Murphy: Clinical Pharmacokinetics pocket reference     Evans:  Applied Pharmacokinetics     Young, Koda-Kimble:  Applied Therapeutics     Herfindal, Gourley, Hart:  Clinical Pharmacy and Therapeutics     Hansten & Horn:  Drug Interactions     Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text       Goals of the Course   To promote the students' understanding of common disease  states with particular emphasis on the facets of diseases  that are amenable to drug therapy.   To familiarize the student with the proper use of drugs in  a clinical setting.    To develop the students' awareness of factors that should be  considered prior to selection of a drug and the appropriate  parameters that should be monitored for therapeutic as well  as undesired effects.   To encourage the students' ability to problem-solve in the  clinical setting.   Performance Objectives 2  Upon completion of this course, each student shall be able to:   Relate the pathophysiology of a disease to the known or purported action of a drug.  Evaluate the seriousness of a disorder based on the signs and symptoms related to a diagnosed problem, and:   --determine the necessity of drug therapy,   --when applicable, choose the proper drug and/or    drug product for the situation.   Determine the place of non-pharmacologic and natural therapies, when applicable.  Tailor the drug therapy of an individual based on patient characteristics and known pharmacokinetics principles.   Identify potential drug-drug interactions.   Monitor the appropriate parameters of a disease to determine if the patient is responding positively to therapy.  Monitor for adverse drug reactions and exacerbations of underlying patient problems resulting from drug therapy.  Student Responsibilities and Obligations   * To attend and participate in lecture sessions.   * To do assigned readings from the texts.  * To attend Integrated Studies conferences, prepare each case in advance, to present a patient case, and participate in the discussion of all patient presentations.   * To perform satisfactorily on course quizzes and lecture examinations.       3 GRADING IN COURSE:  Phar 553 Therapeutics III  3 midterm exams: 100 points each                       300 points  Final exam (comprehensive, multiple choice)                  130 points (100 pts comprehensive, 30 pts over last 6 lectures) Topic quizzes:  8 quizzes graded on 10 pts each   Bonus pts > 75% TOTAL POINTS FOR COURSE                                430 POINTS  Class quizzes:  The purposes of the quizzes are to promote reading of the text before a topic and encourage class attendance and attention.  Quizzes will occur before topic lectures and will test understanding of basic concepts in the reading assignment, and will cover only chapter/reading material associated with the day the quiz is scheduled. A quiz will consist of 5 multiple choice or true/false questions, each worth 2 points.  QUIZ on syllabus indicates a quiz will be given for assigned reading at start of the given lecture.  Lowest 2 quiz grades will be thrown out; no make-ups will be allowed for quiz.  Scoring:  Quiz performance can only benefit student; bonus points for the course will be awarded for all points over 75% (i.e. 60 pts) of the potential total 80 pts on the quizzes (10 total quizzes – 2 throw-outs = 8x10 pts)  NOTE:  Reading assignments are from DiPiro (4th edition) & APhA books  Integrated Studies Conferences: you will be assigned to a conference based on period you registered for; instructors are not necessarily the ones under which you registered.  Attendance/make-up is required for all topics/cases; you may attend a different conference in order to complete the assignment, but ONLY with instructor permission.  The “make-up” requirement for a conference missed due to unavoidable incident will be at the discretion of the instructor, dependent on the topic.  Failure to complete any conference will result in a grade of “fail” for course.  Exams: 3 midterm exams:  Tests will be in "traditional" case report fashion with short answers required.  Tests will be given during a “common” time period.  B.S. and Pharm.D. classes will take tests simultaneously.    Final exam:  65 multiple choice questions worth 2 pts each.  Effort will be made to design questions in the style similar to the NAPLEX exam.  Class civility:  Your student colleagues have strongly indicated to us that they wish to spend their valuable time in class listening to therapeutics topics.  They do not appreciate any “side” conversations while the instructor is lecturing.  They do appreciate students raising questions about important lecture aspects for further discussion or clarification.    Out of respect for your classmates, we will not tolerate excessive and disruptive talking during lecture.  The instructor may first ask you to be silent; you may be asked to leave class if you persist in disruptive talking.  The instructor will be the judge of “what” constitutes disruption.  Please note that we encourage questions and relevant discussion.    Therapeutics 553 Pharm.D.: Lecture Syllabus * denotes “early” 1010-1100 Friday lecture; “joint” denotes B.S. class will join         Instructor Reading Sept  5W Introduction/ Liver disease  MPR     7F* Renal disease/ joint/ QUIZ DRA  40   7F Liver disease    MPR  38     10M Liver Disease    MPR  35  12W Renal disease    DRA  41  14F* Pain Management/ joint   LAB  56  14F Renal disease    DRA  42   17M Pain mgmt/ joint    LAB  19W Headache/ joint/ QUIZ   DB  57  21F*  Headache/ joint    DB  OTC 3  21F Nausea & vomiting    LAB  33, OTC 5   24M N&V, emetics    LAB  OTC 25  25T Career Fair  26W Oncology     CLB  DiPiro pp. 1957-71  28F* Oncology     CLB  pp. 2002-7  28F Oncology     CLB  pp. 2013-41   Oct  1M Oncology     CLB  pp. 2046-57   3W Arthritis / joint/ QUIZ   MPR  84   5F* Arthritis     MPR  83     5F Arthritis/ joint    MPR  OTC pp71-74,OTC 5   5F  Test 1 at 1-3 PM in SB ; through Oncology     8M Gout/ joint     MPR  85  10W Systemic Lupus Erythematosus  LRM  80  12F* Contraception/ joint/ QUIZ  DB  OTC 8  12F Contraception    DB  76   15M Contraception    DB  17W Urinary disorders    DRA  OTC 44   19F* off, in lieu of test 1  19F off, in lieu of test 2 ASP-MRM in Seattle   22M Menopause/ joint/ QUIZ   GAC  78  24W Menopause/ joint    GAC    26F* Osteoporosis/ joint    GAC  82, OTC 419-20  26F off, in lieu of test 3      2  553-Ther III, continued  Oct 29M Osteoporosis/ joint    GAC  31W Obstruct. Airways Dx/ joint/ QUIZ DRA  24 Nov  2F* OAD/ joint     DRA  25, OTC 10   2F Theophylline kinetics   DRA    2F Test 2 at 1-3PM in SB114; through osteoporosis     5M Theophylline PK/respiratory equip DRA   7W Thromboembolic disease/ joint  MPR  17   9F* Stroke/ joint/ QUIZ    MPR  18   9F TED      MPR      12M Veterans Day  14W Peripheral Vascular Disease  MPR  20  16F* Fluid & electrolytes/ QUIZ  SJM  DiPiro pp. 890-902  16F F & E      SJM  pp. 902-16     19M F & E      SJM  21W OFF; TRAVEL DAY  22Th THANKSGIVING HOLIDAY  23F  “ “     26M Nutrition support    SJM  128  28W Nutrition support    SJM  129  30F* Nutrition support    SJM    30F Nutrition support    SJM    Dec  3M Diabetes mellitus/ QUIZ   LRM  70   5W DM      LRM     7F* DM      LRM     7F DM      LRM   7F test 3 at 1-3 PM in SB 114; through nutrition support    10M DM diet/tests    LRM  OTC 39  12W CLASS EVAL/ Thyroid dx/QUIZ  MPR  71  14F* Thyroid disorders/    MPR    14F Thyroid dx     MPR  Final:  test 4, 130 pts comprehensive multiple choice NAPLEX/PSAP format   Merged classes:  for certain classes, B.S. students will merge with the P.D. students, denoted as “joint”- this does not affect P.D. time or location of class.  3 Integrated Studies Phar 571  Monday  0910-1100 SB 111 Macklin Monday  0910-1100 SB 215 Allington Wednesday 0910-1100 SB 215 Rivey Wednesday 0910-1100 SB 335 Allington Wednesday 0910-1100 SB 337 Macklin  I. Conference topics  week of: September  3M  No conference    10M  Liver disease case    17M  Renal Disease case    24M  Headache/pain management  October  1M  J-club for ½ of class; service learning project worksession     8M  Arthritis case    15M  OTC cases    22M  Contraception    29M  service learning update: J-club for other ½ of class  November  5M  SEMINARS      12M  OAD case    19M  off week- holiday week    26M  TED case  December  3M  OTC cases    11M  Evaluation/Diabetes case   Seminar:  A required activity in the course, graded on a pass/no-pass basis.  Student must repeat a no-pass seminar to successfully pass course.  

PHAR 571.01: Integrated Studies IV

https://scholarworks.umt.edu/cgi/viewcontent.cgi?article=7200&amp;context=syllabi

PHAR 571.01: Integrated Studies IV

Abstract

Similar works

Full text

Available Versions

University of Montana